2021-01-03,b'$ALXO https://t.co/RfkpO3fbGR Alx Oncology Holdings Inc Our predictive algorithm estimates the value of this company will lose value in the coming days and is poised to devalue in the coming 90 days #wealth #forex #wallstreet'
2021-01-03,"b'#2020 was a record year. Several stocks did well like $RVMD $TRIL $TPTX $MRNA $ALXO $TDOC $NIO others. \n\nAn unknown follow and #2021 stock pick is $ATHA given to members in Dec. https://t.co/YEXdcxuYcx\n\n#ClubWSE $Study #FF $IBB $XBI \n\nBest, WSE https://t.co/lAtfJhEZaT'"
2021-01-03,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-03,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-03,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-03,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-03,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-03,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-03,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-03,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-02,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-02,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-02,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-02,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-02,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-02,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-02,"b'RT @HedgeMind: 5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show\xe2\x80\xa6'"
2021-01-02,"b'5 hedge funds have delivered at least 45% gains in Q4, the highest among 800+ hedge fund.\xf0\x9f\x91\x87\xf0\x9f\x8f\xbf\n\nEach has one big winner to show:\n\n#1. Nine Ten Capital: $MGNI up 340%\n#2. FJ Capital: $SI +416%\n#3. Logos Global: $ALXO +128%\n#4. Tang Capital: $RCKT +140%\n#5. Tiger Pacific: $PDD +140% https://t.co/B4veryE1KZ'"
2021-01-02,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2021-01-02,"b'$ALXO in -7.54% Downtrend, declining for three consecutive days on December 28, 2020. View odds for this and other indicators: https://t.co/dLSopJkWcz #AlxOncologyHoldings #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/s2YTaJePAd'"
2021-01-02,"b""2020 Return: 53.83% \n\nContinued to reduce software exposure in December and increase bio holdings. \n\nPositions &gt; 1%:\n\n$SNOW $FSLY $PLAN $TXG $NARI $OM $ALNY $HZNP $CCXI $IGMS $KYMR $RLAY\n\nPositions &lt; 1%: \n\n$ALLO $ALVR $ALXO $ANNX $RCUS $ATHA $RNA $BDTX\n$CRIS $DCPH $GBIO\n\ncont'd"""
2021-01-02,b'RT @LuoshengPeng: - The most over-hyped area within biotech will be anti-aging &amp; new IPOs in the space will drive excitement in the new yea\xe2\x80\xa6'
2021-01-02,"b'my biotech holdings on 12/31/2020 are: $CRIS $EXEL $MREO $NBIX $ONCT $SIOX $TCON $CRDF $KPTI $TRIL $VKTX $ALXN , will add $INCY and $ALXO when market opens in the new year. Also holding $BMY and $ABBV.'"
2021-01-02,"b'@LuoshengPeng Which CD47 company is the best ($TRIL, $ALXO, $IMAB) in your opinion?'"
2021-01-02,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-01,b'RT @LuoshengPeng: - The most over-hyped area within biotech will be anti-aging &amp; new IPOs in the space will drive excitement in the new yea\xe2\x80\xa6'
2021-01-01,b'RT @LuoshengPeng: - The most over-hyped area within biotech will be anti-aging &amp; new IPOs in the space will drive excitement in the new yea\xe2\x80\xa6'
2021-01-01,b'RT @LuoshengPeng: - The most over-hyped area within biotech will be anti-aging &amp; new IPOs in the space will drive excitement in the new yea\xe2\x80\xa6'
2021-01-01,b'RT @LuoshengPeng: - The most over-hyped area within biotech will be anti-aging &amp; new IPOs in the space will drive excitement in the new yea\xe2\x80\xa6'
2021-01-01,b'- The most over-hyped area within biotech will be anti-aging &amp; new IPOs in the space will drive excitement in the new year\n\n- At least two CD47 companies will be acquired &amp; $TRIL $ALXO $IMAB are biotechs working on CD47 drugs\n\n5/'
2021-01-01,"b'2 CD47s Acquired? \n\nMay be aggressive, but I\xe2\x80\x99ll bite:\n\n$MRK \xe2\x80\x94&gt; $ALXO +/- JPM21 \n\n- see venBio (Goodman/Pons) &amp; $MRK connection (let alone $MRK / $ALXO clinical collab) \n\n$PFE \xe2\x80\x94&gt; $TRIL ~ ASH21 \n\nAfter some 621 combo PoC in heme + solid (mBC?) \n                         .   .   . https://t.co/GUd4SeWrIL https://t.co/ylB2GVCCiS'"
2021-01-01,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- ALX148 is all too human.\n\nPerhaps ther\xe2\x80\xa6'"
2021-01-01,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-01,b'RT @BrandonVanZee: One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a\xe2\x80\xa6'
2021-01-01,"b""Much smaller than $TRIL though. I see no reason why $ALXO won't end up with\xc2\xa0+$5B market cap. And it will do it before $TRIL simply due to being ahead and being partnered with a much\xc2\xa0stronger partner in Merck."""
2021-01-01,"b""And why wouldn't $ALXO be valued much higher than $TRIL at this point in time? I think there is room for both $TRIL and $ALXO and I can't see any reason why $ALXO won't succeed (too). Hence, I have taken a position in $ALXO too at &lt;$80."""
2021-01-01,"b""If $ALXO can show meaningful and significant combo data with Keytruda why wouldn't Merck be very interested?"""
2021-01-01,"b'While I also believe $TRIL has the better overall drug in TTI-622 compared to $ALXO and $GILD, this is not all. Timing and partnerships are key too. $ALXO are years ahead in combo trials, they have partnered with Merck and are doing combos with Keytruda, a huge blockbuster drug.'"
2021-01-01,b'One of my favorite routines of New Year\xe2\x80\x99s Day is to view the IBD run-down of the previous year\xe2\x80\x99s winners. It tells you a lot about what themes were in style each year!\n\n$TSLA $FVRR $TWST $ENPH $PTON $MRNA $CVAC $RUN $ZM $SE $DNLI $BEAM $PDD $SI $SDGR $FATE $BILI $NARI $ALXO $NET https://t.co/ddsdxwmNtS'
2021-01-01,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- ALX148 is all too human.\n\nPerhaps ther\xe2\x80\xa6'"
2021-01-01,"b'$ALXO in -7.54% Downtrend, declining for three consecutive days on December 28, 2020. View odds for this and other indicators: https://t.co/ysoBl1U1WI #AlxOncologyHoldings #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Yk7VWmmxwn'"
2021-01-01,b'RT @earningsflyinc: Top 15 Healthcare stocks with market cap over 1 billion in 60 days. \n\nhttps://t.co/IMOeAqOzdo\n\n$ALXO $CDXS $ALGN $CDNA\xe2\x80\xa6'
2021-01-01,b'Top 15 Healthcare stocks with market cap over 1 billion in 60 days. \n\nhttps://t.co/IMOeAqOzdo\n\n$ALXO $CDXS $ALGN $CDNA $ACHC $ONEM $MD $THC $RCUS $STAA $BHC $TARO $NNOX $HCA $GMED\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/XsorwrJ2Ii'
2021-01-01,b'@PersimmonTI When $PFE buys them they will ru. $ALXO a into the ground.'
2021-01-01,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior \n\nAddendum:  ALX148 is all too human.\n\nSo\xe2\x80\xa6'"
2021-01-01,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- ALX148 is all too human.\n\nPerhaps there is something to those assertions, \n\nbut $ALXO's own words beg to differ:\n                       .  .  . https://t.co/e53doDNezH"""
2021-01-01,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior \n\nAddendum:  ALX148 is all too human.\n\nSome commentary about how $TRIL patent doesn't reach ALX148 because of compositional differences--\n\nDo such arguments hold merit?\n                     .  .  . https://t.co/kSKJXf6fgC https://t.co/UGlYSboNSS"""
2020-12-31,"b'RT @tradingwisdom14: $TRIL was way oversold on Phase 1 data that was judged like it was phase 3. Cut me a break,there ORR still lays $ALXO\xe2\x80\xa6'"
2020-12-31,"b'RT @PersimmonTI: $XBI\n\n$ALXO $IMAB $TRIL $RCUS $MREO $SURF $JNCE \n\nAn interesting read that adds context, and adds some important questions\xe2\x80\xa6'"
2020-12-31,"b'$TRIL was way oversold on Phase 1 data that was judged like it was phase 3. Cut me a break,there ORR still lays $ALXO to rest in mono-therapy.  And combo argument is baseless by $ALXO\n\nAlso, relentless buying this morning for $TRIL chart looks great. #bottombeenin'"
2020-12-31,"b'RT @PersimmonTI: $XBI\n\n$ALXO $IMAB $TRIL $RCUS $MREO $SURF $JNCE \n\nAn interesting read that adds context, and adds some important questions\xe2\x80\xa6'"
2020-12-31,"b'$XBI\n\n$ALXO $IMAB $TRIL $RCUS $MREO $SURF $JNCE \n\nAn interesting read that adds context, and adds some important questions, about I/O modalities headed into the new year: https://t.co/YBOgVdWBzp'"
2020-12-31,"b""RT @PersimmonTI: $TRIL\n\nI'm thinking that some shorts' britches are feeling a bit warm... \n\nMore to follow on $TRIL / $ALXO and patent, lat\xe2\x80\xa6"""
2020-12-31,"b""$TRIL\n\nI'm thinking that some shorts' britches are feeling a bit warm... \n\nMore to follow on $TRIL / $ALXO and patent, later today.\n\nA happy early New Year wish to all (even the shorts). https://t.co/0CO4SK0R0I"""
2020-12-31,b'Top 15 Healthcare stocks with market cap over 1 billion in 60 days. \n\nhttps://t.co/IMOeAqwXOO\n\n$ALXO $CDXS $CDNA $ALGN $ACHC $ONEM $RCUS $THC $STAA $MD $TARO $GMED $ENSG $TECH $HCA\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/mTRyfusqMq'
2020-12-31,b'Top 15 Healthcare stocks with market cap over 1 billion today. \n\nhttps://t.co/sY1okINKJw\n\n$CDXS $AXNX $ALXO $OLMA $OTRK $ACHC $CERT $ZYME $STAA $CDNA $OSH $GNMK $DXCM $ONEM $JNJ\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/tzkXpWIxuH'
2020-12-30,"b'@E_McClintock_ I think it\xe2\x80\x99s really important. May keep suitors away from $alxo and into $tril, plus adds value to $tril TO price'"
2020-12-30,b'@jayabacus How important do you see the $TRIL patent situation being as an advantage over competitors like $ALXO?'
2020-12-30,b'Top 15 Healthcare stocks with market cap over 1 billion in 60 days. \n\nhttps://t.co/IMOeAqOzdo\n\n$ALXO $CDXS $CDNA $ALGN $RCUS $ACHC $THC $ONEM $MD $STAA $TARO $GMED $BHVN $HCA $ENSG\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/5z1GgKmL2m'
2020-12-30,b'Top 15 Healthcare stocks with market cap over 1 billion today. \n\nhttps://t.co/x53mc2KUXv\n\n$FLGT $SGRY $ZBH $GSK $BSX $TARO $MRK $RGEN $AZN $TAK $BAX $ALXO $SNY $PFE $JNJ\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/eHp6pkuJJY'
2020-12-30,"b""@markminervini Its almost like the stocks we trade in were targeted!\n\nI'm tightening my stops just like you recommend and bailed on three.\n\nStill up 76.63% $ALXO 18.22% $CSTL 16.89% $VRNS"""
2020-12-30,b'We know blocking CD47 helps treat cancer. Could it also help w/ long COVID? Millions of people may end up with long term effects from COVID including lung fibrosis and myocardial infarction.  Could $TRIL $ALXO $STTK help?\n\nhttps://t.co/XKcW5Ns55p \n\nhttps://t.co/VeJCmPPzG1'
2020-12-29,"b""$TRIL $ALXO\n\nCD47s doing the ol' post Christmas red to green 'tis afternoon. \n\nLots of low volume selling, in general  $XBI"""
2020-12-29,b'RT @jfais20: $ALXO another good one to accumulate each time it falls below SMA 20\n\nEarly data shows superior response rates versus SOC in m\xe2\x80\xa6'
2020-12-29,b'20 DMA Support today: $PEG $PLD $ALXO ... https://t.co/deOpbNqdR6'
2020-12-29,"b'$ALXO another good one to accumulate each time it falls below SMA 20\n\nEarly data shows superior response rates versus SOC in multiple solid tumor indications\n\nSo much they can pursue, seems like a no brainer for pharma to buyout and accelerate clinical development https://t.co/XgQYSe700C'"
2020-12-29,b'That $Alxo money going straight into $TRIL https://t.co/9LIngZEIuX'
2020-12-29,b'$ALXO broke support of trend and EMA20. EMA50 next support. No position here. https://t.co/3s8JBio3OP'
2020-12-29,b'$EDIT -15%\n$BEAM -12%\n$ALXO -8%\n$SYRS -13%\n$FATE -7%\n$ATNM -25%'
2020-12-29,"b'There goes $ALXO, broke EMA20 support and trend. EMA50 next'"
2020-12-29,b'Top 15 Healthcare stocks with market cap over 1 billion in 60 days. \n\nhttps://t.co/IMOeAqOzdo\n\n$ALXO $NNOX $CDXS $CDNA $RCUS $ALGN $THC $ACHC $MD $ONEM $STAA $GMED $BHVN $TARO $HCA\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/YhP9fYZcXF'
2020-12-28,b'https://t.co/RfkpO3fbGR Alx Oncology Holdings Inc The mathematical model is forecasting the price of this stock will depreciate in the short term and has a negative long term outlook $ALXO #wealth #forex #trader'
2020-12-28,"b'Evening Most Tweeted Mid Caps, check out Gambiste Top 10: $BMI $SRNE $CRSR $NKLA $NOV $ALXO $LMND $mstr $FCEL https://t.co/k3uyuEbRpJ'"
2020-12-28,"b'Afternoon Most Tweeted Mid Caps, check out Gambiste Top 10: $BMI $SRNE $CRSR $NKLA $NOV $ALXO $LMND $mstr $FCEL https://t.co/k3uyuEbRpJ'"
2020-12-28,b'$ALXO is today ranked #5 in the Daily Gambiste Mid Cap rating. ALX Oncology Holdings Inc. - Common Stock is today top rated. Check the full Gambiste long term ratings here: https://t.co/RA0LXyNU1n'
2020-12-28,"b""RT @WayoftheMaster7: Hit em if you want em! #TheStrat \n\nInside D Add's... $ALLK $ENPH $BEAM $CCCC $RUN $WMG $CSII $BE $BRBR $AOSL $SWBI $YE\xe2\x80\xa6"""
2020-12-28,"b""RT @WayoftheMaster7: Hit em if you want em! #TheStrat \n\nInside D Add's... $SWTX $ALGM $CLSK $NGA $KOD $BILI $SEDG $SPWR $TME $BILL\n\n3-1 D..\xe2\x80\xa6"""
2020-12-28,"b'Midday Most Tweeted Mid Caps, check out Gambiste Top 10: $BMI $SRNE $CRSR $NKLA $ALXO $NOV $mstr $WKHS $FCEL $LMND https://t.co/k3uyuEbRpJ'"
2020-12-28,b'RT @MatthewLepoire: 080 - Trillium Therapeutics vs. ALX Oncology? The CD47 Space Races to a Pivotal Trial https://t.co/JTgcR9JvJG $TRIL $AL\xe2\x80\xa6'
2020-12-28,b'RT @MatthewLepoire: 080 - Trillium Therapeutics vs. ALX Oncology? The CD47 Space Races to a Pivotal Trial https://t.co/JTgcR9JvJG $TRIL $AL\xe2\x80\xa6'
2020-12-28,b'RT @wyv_123: @srqstockpicker They were and still are IMO. It\xe2\x80\x99s telling how $ALXO always disparages $TRIL in every way possible except IP wh\xe2\x80\xa6'
2020-12-28,b'@srqstockpicker They were and still are IMO. It\xe2\x80\x99s telling how $ALXO always disparages $TRIL in every way possible except IP where they say nothing.'
2020-12-28,b'RT @SteelyRivers: Thank you for taking the time to educate others on the two reasons I have always thought $ALXO was inferior to $TRIL:  th\xe2\x80\xa6'
2020-12-28,b'RT @wyv_123: @PersimmonTI dropped the $TRIL hammer on $ALXO and @srqstockpicker finishes them off. https://t.co/LaTT2OmkSO'
2020-12-28,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-28,b'RT @SteelyRivers: That $ALXO has been low volume pumped is a testament to the underwriters of the IPO and the holders of the initial offeri\xe2\x80\xa6'
2020-12-28,b'RT @SteelyRivers: Thank you for taking the time to educate others on the two reasons I have always thought $ALXO was inferior to $TRIL:  th\xe2\x80\xa6'
2020-12-28,b'RT @wyv_123: @PersimmonTI dropped the $TRIL hammer on $ALXO and @srqstockpicker finishes them off. https://t.co/LaTT2OmkSO'
2020-12-28,b'RT @earningsflyinc: Top 15 Healthcare stocks with market cap over 1 billion in 60 days. \n\nhttps://t.co/IMOeAqOzdo\n\n$ALXO $NNOX $CDNA $CDXS\xe2\x80\xa6'
2020-12-28,b'RT @wyv_123: @PersimmonTI dropped the $TRIL hammer on $ALXO and @srqstockpicker finishes them off. https://t.co/LaTT2OmkSO'
2020-12-28,b'$ALXO could still make a move with a target above the $117 area (w/ PR maybe) but this type of chart is generally bearish.  Watch that it stays above EMA20 for any continued upward movement. EMA50 immediate support after EMA20. https://t.co/h8UyxiTwyT'
2020-12-28,"b'RT @SteelyRivers: @Persimmon_Plus Good work. The timing is right, because accumulation showing in chart as RSI is recovering, and $ALXO is\xe2\x80\xa6'"
2020-12-28,"b'@Persimmon_Plus Good work. The timing is right, because accumulation showing in chart as RSI is recovering, and $ALXO is over-hyped on low volume.'"
2020-12-28,"b'That $ALXO has been low volume pumped is a testament to the underwriters of the IPO and the holders of the initial offering: there is no place for underwriters on the $tril story, so they have pumped it. Zero shares of $ALXO in my bag.'"
2020-12-28,"b""Thank you for taking the time to educate others on the two reasons I have always thought $ALXO was inferior to $TRIL:  the former hasn't shown efficacy at the $TRIL level, not the same safety profile; and $TRIL has the patent advantage, clear and not in doubt./1 https://t.co/7bh2IEuoSp"""
2020-12-28,b'RT @wyv_123: @PersimmonTI dropped the $TRIL hammer on $ALXO and @srqstockpicker finishes them off. https://t.co/LaTT2OmkSO'
2020-12-28,b'RT @jordicunill: @PersimmonTI I\xe2\x80\x99m lately surprised on market cap differences amongst CD47 players. $STTK is 2.4B$ $ALXO is 3.3B$ and $TRIL\xe2\x80\xa6'
2020-12-28,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-28,b'RT @wyv_123: @PersimmonTI dropped the $TRIL hammer on $ALXO and @srqstockpicker finishes them off. https://t.co/LaTT2OmkSO'
2020-12-28,b'RT @wyv_123: @PersimmonTI dropped the $TRIL hammer on $ALXO and @srqstockpicker finishes them off. https://t.co/LaTT2OmkSO'
2020-12-28,b'RT @wyv_123: @PersimmonTI dropped the $TRIL hammer on $ALXO and @srqstockpicker finishes them off. https://t.co/LaTT2OmkSO'
2020-12-28,"b""RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 2 of 14\n\nLet's keep th\xe2\x80\xa6"""
2020-12-28,b'@PersimmonTI dropped the $TRIL hammer on $ALXO and @srqstockpicker finishes them off. https://t.co/LaTT2OmkSO'
2020-12-28,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- Addendum to come?\n\nALX148 is all too h\xe2\x80\xa6'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 14 of 14\n\nI wonder who\xe2\x80\xa6'"
2020-12-27,"b""RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 13 of 14\n\nIt'll probab\xe2\x80\xa6"""
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 12 of 14\n\nThe Patent B\xe2\x80\xa6'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 11 of 14\n\nUnrebutted e\xe2\x80\xa6'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-27,"b'@Sam_The_Seed Namaste, here is your unroll: @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread $TRIL\xe2\x80\xa6 https://t.co/ayG9VZOpsS Enjoy :) \xf0\x9f\xa4\x96'"
2020-12-27,"b'RT @PersimmonTI: $TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-27,"b'$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- Addendum to come?\n\nALX148 is all too human...'"
2020-12-27,"b'$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 14 of 14\n\nI wonder who likes strong IP positions? \n\nAs always, bring the data -- but the IP?  Well, that story is already being written: \n          . . . https://t.co/j0RKJQKcPZ'"
2020-12-27,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 13 of 14\n\nIt'll probably never reach court, but if it does -- USPTO's rationale for reversal is a strength to $TRIL patent\n\nPresupposed obviousness, already overcome:\n  .  . https://t.co/iqwwk2k7XB"""
2020-12-27,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 12 of 14\n\nThe Patent Battle's Won, but so what? \n\nOne small step, but it could be a giant leap in a giant's hands: \n                   .  .  . https://t.co/oLUyyHrXwD"""
2020-12-27,"b'$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 11 of 14\n\nUnrebutted evidence of $TRIL 621 &amp; 622 differentiation with respect to RBC binding and agglutination-- \n\ngood for patent, great for patient: \n        . . . https://t.co/znSdIRXkm4'"
2020-12-27,"b'$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 10 of 14\n\nBut, the $TRIL patent tide turns with an unexpected result -- and a $TRIL slide illustrates that result, well: \n                    .  .  . https://t.co/WNu36R5Yzc'"
2020-12-27,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 9 of 14\n\nInitially, $TRIL's claim was all to obvious to the USPTO -- in other words, not patentable... \n              . . . https://t.co/339QP74NVe"""
2020-12-27,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 8 of 14\n\nIP law is murky at best of times, but still, USPTO's reversal, in favor of $TRIL is promising in particular because of its rationale for reversal (more, later):\n. https://t.co/6DZTR6536I"""
2020-12-27,"b'$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 7 of 14\n\nNarrow, yes -- but what about Shattuck Labs ( $STTK ) ?\n                      .  .  . https://t.co/iNhWySy8kg'"
2020-12-27,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 6 of 14\n\nSo, what's it all mean? What are the potential practical applications?  \n\nWell, it's both Narrow, and Broad: \n                          . . . https://t.co/4kwf2NqNYk"""
2020-12-27,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 5 of 14\n\nAnd, here's the meat of the claim -- the method of use, and for what purpose:\n              .  .  . https://t.co/YvUxjEUMY5"""
2020-12-27,"b'$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 4 of 14\n\nTake note that, as $TRIL points out, the method of use covers both heme malignancies and solid tumors:\n              .  .  . https://t.co/mPlcHdboQh'"
2020-12-27,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 3 of 14\n\n$TRIL's intellectual claim -- it's about fusion, and method of use -- and the implications are interesting: \n                           . . . https://t.co/SBKcvDIoHi"""
2020-12-27,"b""$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread -- 2 of 14\n\nLet's keep things in perspective -- no one's going to court just yet (or ever) --\n\nBut an incremental positive for $TRIL's differentiated science:\n           .    .   . https://t.co/mruo4erz5K"""
2020-12-27,"b'$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread \n\nTrillium, in usual understated style, relays the good news of its patent victory in its latest corporate deck.\n\nI juxtapose that news against the now famous CD47 comparo slide: \n - https://t.co/We3mLF9xek'"
2020-12-27,"b'$TRIL $ALXO -- Trillium Patent Vindicated; Nonobvious, and Unexpectedly Superior -- A PTI Thread https://t.co/dCOBEmOCt8'"
2020-12-27,b'RT @jordicunill: @PersimmonTI I\xe2\x80\x99m lately surprised on market cap differences amongst CD47 players. $STTK is 2.4B$ $ALXO is 3.3B$ and $TRIL\xe2\x80\xa6'
2020-12-27,"b'RT @semodough: JEFF 2022Top M&amp;A ideas include: $ACAD, $ALLK $TGTX $ALXO, $IOVA, $CNST,   Honestly not sure what my reaction will be if $TGT\xe2\x80\xa6'"
2020-12-27,b'Excellent presentation on #CD47 and overview on $tril and $alxo . Thank you @bigliu https://t.co/I44oKPkRke'
2021-01-07,b'added $MGNI $ALXO $BIPC $UONE. https://t.co/bBkGtMFhNL'
2021-01-07,b'$ALXO NEW ARTICLE : ALX Oncology: All Their Eggs In The Proverbial Basket https://t.co/EXjTJsPUX6 Get all the latest $ALXO related news here : https://t.co/JItbfDC9hj'
2021-01-07,b'$ALXO - ALX Oncology: All Their Eggs In The Proverbial Basket. https://t.co/jd2ZMwd8HJ #finance #investing #markets'
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'$ALXO in -8.32% Downtrend, falling for three consecutive days on January 4, 2021. View odds for this and other indicators: https://t.co/qUHxmewVOP #AlxOncologyHoldings #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MrxEWh9CSp'"
2021-01-07,b'RT @Biotech2k1: My New Top 10:\n\n1. $GBIO\n2. $CABA\n3. $TRIL\n4. $RNA\n5. $TCRR\n6. $ALXO\n7. $BPMC\n8. $FDMT\n9. $KNTE\n10. $YMAB\n\nI removed all th\xe2\x80\xa6'
2021-01-07,"b'RT @jfais20: $XBI $IBB To gain exposure to a particular theme or class of drugs, a \xc2\xa8basket approach\xc2\xa8 is often optimal (balances diversifica\xe2\x80\xa6'"
2021-01-07,"b'$XBI $IBB To gain exposure to a particular theme or class of drugs, a \xc2\xa8basket approach\xc2\xa8 is often optimal (balances diversification, risk and upside)\n\nie equal parts $ALXO $TRIL in CD47\n\n$ARWR $DRNA $ALNY in RNAi\n\nWhat others come to mind for you?'"
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'RT @PersimmonTI: The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells\xe2\x80\xa6'"
2021-01-07,"b'The Year of the NK Cell &amp; Innate Immunity \n\nThe great Uncovering that began in 2020, will continue to gather steam\xe2\x80\x94\n\nCells:  $FATE $AFMD $GMDA $NKTX\n\nCheckpoints:  $TRIL $ALXO $IMAB $STTK $CRIS (?)'"
2021-01-07,b'RT @Biotech2k1: My New Top 10:\n\n1. $GBIO\n2. $CABA\n3. $TRIL\n4. $RNA\n5. $TCRR\n6. $ALXO\n7. $BPMC\n8. $FDMT\n9. $KNTE\n10. $YMAB\n\nI removed all th\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: My New Top 10:\n\n1. $GBIO\n2. $CABA\n3. $TRIL\n4. $RNA\n5. $TCRR\n6. $ALXO\n7. $BPMC\n8. $FDMT\n9. $KNTE\n10. $YMAB\n\nI removed all th\xe2\x80\xa6'
2021-01-07,b'My New Top 10:\n\n1. $GBIO\n2. $CABA\n3. $TRIL\n4. $RNA\n5. $TCRR\n6. $ALXO\n7. $BPMC\n8. $FDMT\n9. $KNTE\n10. $YMAB\n\nI removed all the bubbly fairy tale stocks and built a list of potential next fairy tale stocks. All are high risk and some will most likely fail so word of caution.'
2021-01-07,b'Top 15 Healthcare stocks with market cap over 1 billion in 60 days. \n\nhttps://t.co/IMOeAqOzdo\n\n$ALXO $ALGN $ACHC $THC $CDXS $FLGT $RCUS $ENSG $MD $ONEM $TARO $CDNA $STAA $SGRY $HCA\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/9T6v3MsXUC'
2021-01-07,b'RT @Biotech2k1: My Antibodies List for 2021:\n\n1. $YMAB *\n2. $MRSN *\n3. $ALXO after lock up\n4. $TRIL *\n5. $ZYME\n6. $BCAB\n7. $STRO\n\n* compani\xe2\x80\xa6'
2021-01-07,b'RT @Biotech2k1: My Antibodies List for 2021:\n\n1. $YMAB *\n2. $MRSN *\n3. $ALXO after lock up\n4. $TRIL *\n5. $ZYME\n6. $BCAB\n7. $STRO\n\n* compani\xe2\x80\xa6'
2021-01-06,b'@srqstockpicker What would be even better is if $alxo did $ftsv trick from last year.'
2021-01-06,"b'RT @AndrewE_Dunn: The best-performing biotech IPOs of 2020, according to Jefferies: \n\n1. Curevac $CVAC +407%\n2. Beam Tx $BEAM +380%\n3. Schr\xe2\x80\xa6'"
2021-01-06,"b""$ALXO fake pullback with a possible rebound to $117 and beyond? we'll see if it can retain support in coming days. https://t.co/obe97bcgBj"""
2021-01-06,b'What is your favorite new target in AML?\n$FTSV $ALXO $TRIL $KURA $SNDX $CRIS $SYRS $APRE'
2021-01-06,"b'RT @AndrewE_Dunn: The best-performing biotech IPOs of 2020, according to Jefferies: \n\n1. Curevac $CVAC +407%\n2. Beam Tx $BEAM +380%\n3. Schr\xe2\x80\xa6'"
2021-01-06,b'RT @semodough: CANTOR $ALXO ALX148 is shaping up as a potential standout in solid tumor- Increase PT to $103.    $TRIL'
2021-01-06,"b'RT @AndrewE_Dunn: The best-performing biotech IPOs of 2020, according to Jefferies: \n\n1. Curevac $CVAC +407%\n2. Beam Tx $BEAM +380%\n3. Schr\xe2\x80\xa6'"
2021-01-06,"b'RT @AndrewE_Dunn: The best-performing biotech IPOs of 2020, according to Jefferies: \n\n1. Curevac $CVAC +407%\n2. Beam Tx $BEAM +380%\n3. Schr\xe2\x80\xa6'"
2021-01-06,"b'RT @AndrewE_Dunn: The best-performing biotech IPOs of 2020, according to Jefferies: \n\n1. Curevac $CVAC +407%\n2. Beam Tx $BEAM +380%\n3. Schr\xe2\x80\xa6'"
2021-01-06,"b'RT @AndrewE_Dunn: The best-performing biotech IPOs of 2020, according to Jefferies: \n\n1. Curevac $CVAC +407%\n2. Beam Tx $BEAM +380%\n3. Schr\xe2\x80\xa6'"
2021-01-06,b'Alx Oncology $ALXO target raised by Cantor  Fitzgerald from $64 to $103 at Overweight. Stock currently around $85.\n\n$SPY $QQQ $TSLA $AAPL $AMZN $MSFT $BABA $GOOG $NVDA $NIO $FB $FSR $PTON $TDOC $SQ $PENN $DKNG $TWTR $BA $XPEV $PLTR $BYND $MRNA $PFE $LI $SOLO https://t.co/KT2oPNjljR'
2021-01-06,"b'The best-performing biotech IPOs of 2020, according to Jefferies: \n\n1. Curevac $CVAC +407%\n2. Beam Tx $BEAM +380%\n3. Schrodinger $SDGR +366%\n4. ALX Oncology $ALXO +354%\n5. Keros Tx $KROS +341%'"
2021-01-06,b'$ALXO\nALXO Target Raised by Cantor Fitzgerald with price target $64.00 \xe2\x9e\x9d $103.00 and rating Overweight\nSource:https://t.co/cLuXiVHuP1\n\n$AMAT\nAMAT Target Raised by KeyCorp with price target $89.00 \xe2\x9e\x9d $104.00 and rating... https://t.co/TcP4zOa72c'
2021-01-06,"b'RT @PersimmonTI: $ALXO \n\nSome recent PT increases, incl Cantor, before a plum presentation spot at upcoming JPM.  \n\nThe pieces are there fo\xe2\x80\xa6'"
2021-01-06,"b'$ALXO \n\nSome recent PT increases, incl Cantor, before a plum presentation spot at upcoming JPM.  \n\nThe pieces are there for potential BD/MA activity in the near term. \n\nWould have $TRIL ing implications, should something come to pass. https://t.co/zpozJvkidB'"
2021-01-06,b'@semodough Extremely bold when 50% of the outstanding shares come off lock up in another week. Last run before the big crash if you ask me. I like $ALXO and would own it once this bubble pops after lock up.'
2021-01-06,b'RT @semodough: CANTOR $ALXO ALX148 is shaping up as a potential standout in solid tumor- Increase PT to $103.    $TRIL'
2021-01-06,b'CANTOR $ALXO ALX148 is shaping up as a potential standout in solid tumor- Increase PT to $103.    $TRIL'
2021-01-06,b'RT @BioStocks: $ALXO PT raised to $103 from $64 at Cantor. $TRIL'
2021-01-06,b'$ALXO PT raised to $103 from $64 at Cantor. $TRIL'
2021-01-06,b'ALX Oncology price target raised to $103 from $64\n$ALXO'
2021-01-06,b'$ALXO https://t.co/RfkpO3fbGR Alx Oncology Holdings Inc The network is forecasting that this stock s value will shortly go down and is facing significant downsides in the longer term #finance #investor #credit'
2021-01-06,b'ALX Oncology to Present at 39th Annual J.P. Morgan Healthcare Conference $ALXO https://t.co/lmakJVFRP4'
2021-01-06,b'Top 15 Healthcare stocks with market cap over 1 billion in 60 days. \n\nhttps://t.co/IMOeAqOzdo\n\n$ALXO $ALGN $ACHC $CDXS $THC $ONEM $CDNA $STAA $FLGT $MD $RCUS $ENSG $TARO $HCA $SGRY\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/EwPxVJMjEV'
2021-01-06,b'Top 15 Healthcare stocks with market cap over 1 billion today. \n\nhttps://t.co/KOFFwwdTa5\n\n$EAR $SEER $FLGT $ENSG $THC $ALXO $EXEL $HOLX $ZYME $LMNX $SGRY $ALGN $DXCM $BSX $GNMK\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/YrOvoQEax0'
